- Report
- February 2025
- 150 Pages
Global
From €3427EUR$3,850USD£2,982GBP
€4318EUR$4,850USD£3,756GBP
- Report
- February 2025
- 150 Pages
Global
From €3427EUR$3,850USD£2,982GBP
€4318EUR$4,850USD£3,756GBP
- Report
- February 2025
- 150 Pages
Global
From €3427EUR$3,850USD£2,982GBP
€4318EUR$4,850USD£3,756GBP
- Report
- February 2025
- 150 Pages
Global
From €3427EUR$3,850USD£2,982GBP
€4318EUR$4,850USD£3,756GBP
- Report
- December 2024
- 150 Pages
Global
From €3427EUR$3,850USD£2,982GBP
€4318EUR$4,850USD£3,756GBP
- Report
- November 2024
- 150 Pages
Global
From €3427EUR$3,850USD£2,982GBP
€4318EUR$4,850USD£3,756GBP
- Report
- August 2025
- 250 Pages
Global
From €3997EUR$4,490USD£3,477GBP
- Report
- August 2025
- 250 Pages
Global
From €3997EUR$4,490USD£3,477GBP
- Report
- August 2025
- 250 Pages
Global
From €3997EUR$4,490USD£3,477GBP
- Report
- April 2025
- 175 Pages
Global
From €3997EUR$4,490USD£3,477GBP
- Report
- April 2025
- 175 Pages
Global
From €3997EUR$4,490USD£3,477GBP
- Report
- April 2025
- 175 Pages
Global
From €3997EUR$4,490USD£3,477GBP
- Report
- April 2025
- 175 Pages
Global
From €3997EUR$4,490USD£3,477GBP
- Report
- April 2025
- 200 Pages
Global
From €3997EUR$4,490USD£3,477GBP
- Report
- April 2025
- 200 Pages
Global
From €3997EUR$4,490USD£3,477GBP
- Report
- March 2025
- 294 Pages
Global
From €3997EUR$4,490USD£3,477GBP
- Report
- March 2025
- 200 Pages
Global
From €3997EUR$4,490USD£3,477GBP
- Report
- March 2025
- 175 Pages
Global
From €3997EUR$4,490USD£3,477GBP
- Report
- February 2025
- 200 Pages
Global
From €3997EUR$4,490USD£3,477GBP
- Report
- February 2025
- 200 Pages
Global
From €3997EUR$4,490USD£3,477GBP

The Vaccine Manufacturing market is a subset of the biopharmaceutical industry, which focuses on the development and production of vaccines. Vaccines are biological products that are used to prevent and treat infectious diseases. Vaccine manufacturing involves the production of active ingredients, such as antigens, as well as the formulation and packaging of the final product. Vaccine manufacturers must adhere to strict regulatory standards to ensure the safety and efficacy of their products.
The Vaccine Manufacturing market is highly competitive, with a number of large pharmaceutical companies and biotechnology firms competing for market share. Companies in the market include Merck & Co., GlaxoSmithKline, Sanofi, Pfizer, Johnson & Johnson, and Novavax. Show Less Read more